01/02/2025
7:02 PM | Athira Pharma (Subject)
CHURCH KEVIN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2025
7:04 PM | Athira Pharma (Subject)
Worthington Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2025
7:05 PM | Athira Pharma (Subject)
Litton Mark James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2025
7:06 PM | Athira Pharma (Subject)
San Martin Javier (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024
12:15 PM | Athira Pharma (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G | |
10/31/2024
3:16 PM | Athira Pharma (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
10/28/2024
11:15 PM | Athira Pharma (Filer)
| Form EFFECT | |
10/21/2024
5:24 AM | Athira Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/03/2024
8:50 PM | Athira Pharma (Issuer)
Litton Mark James (Reporting)
| Form 4/A | |
10/03/2024
6:07 PM | Athira Pharma (Issuer)
Litton Mark James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
6:08 PM | Athira Pharma (Issuer)
Worthington Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/03/2024
6:10 PM | Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
6:13 PM | Athira Pharma (Issuer)
San Martin Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
6:17 PM | Athira Pharma (Issuer)
Renninger Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
6:05 PM | Athira Pharma (Issuer)
Renninger Robert (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/17/2024
8:00 AM | Athira Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
6:47 PM | Athira Pharma (Issuer)
Litton Mark James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:48 PM | Athira Pharma (Issuer)
Worthington Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:49 PM | Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:50 PM | Athira Pharma (Issuer)
Lenington Rachel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:51 PM | Athira Pharma (Issuer)
Gengos Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:53 PM | Athira Pharma (Subject)
Litton Mark James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
3:15 PM | Athira Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/25/2024
6:21 PM | Athira Pharma (Issuer)
Romano Kelly A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:05 PM | Athira Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
5:54 PM | Athira Pharma (Issuer)
FLUKE JOHN M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
5:55 PM | Athira Pharma (Issuer)
PICKERING GRANT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
5:56 PM | Athira Pharma (Issuer)
Panzara Michael A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
5:58 PM | Athira Pharma (Issuer)
Kosacz Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:00 PM | Athira Pharma (Issuer)
JOHNSON JAMES A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:01 PM | Athira Pharma (Issuer)
EDELMAN JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:03 PM | Athira Pharma (Issuer)
Romano Kelly A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:34 PM | Athira Pharma (Issuer)
San Martin Javier (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/16/2024
3:37 PM | Athira Pharma (Issuer)
San Martin Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
7:32 AM | Athira Pharma (Filer)
| Form DEF 14A | |
04/09/2024
7:34 AM | Athira Pharma (Filer)
| Form DEFA14A | |
04/09/2024
7:35 AM | Athira Pharma (Filer)
| Form ARS | |
03/28/2024
7:47 AM | Athira Pharma (Filer)
| Form PRE 14A | |
02/22/2024
3:34 PM | Athira Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/22/2024
3:15 PM | Athira Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/16/2024
3:46 PM | Athira Pharma (Issuer)
Lenington Rachel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy this coin BEFORE Inauguration Day … (Ad) Mark my words … Bitcoin is going to $100,000.
BEFORE Trump is inaugurated.
And I think it could reach $125,000 by the end of his first month in office. This could be his favorite coin. |
02/16/2024
3:48 PM | Athira Pharma (Issuer)
Gengos Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:54 PM | Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:32 PM | Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
| Form 4/A | |
02/16/2024
3:34 PM | Athira Pharma (Issuer)
Gengos Andrew (Reporting)
| Form 4/A | |
02/16/2024
3:37 PM | Athira Pharma (Issuer)
Worthington Mark (Reporting)
| Form 4/A | |
02/16/2024
3:38 PM | Athira Pharma (Issuer)
Litton Mark James (Reporting)
| Form 4/A | |
02/16/2024
3:40 PM | Athira Pharma (Issuer)
Lenington Rachel (Reporting)
| Form 4/A | |
